 | • レポートコード：GIR-105X15199 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ビガバトリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ビガバトリンの種類別市場規模（錠剤、粉末）、用途別市場規模（点頭てんかん（IS）、部分発作、難治性複合部分発作）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ビガバトリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi、Benta Pharma Industries、Dr. Fisher Farma、Lundbeck、Novartis、Perrigo、Grindeks、Endo International、Amneal Pharma、Cipla、Upsher-Smith ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：錠剤、粉末 ・用途別分析2016年-2026年：点頭てんかん（IS）、部分発作、難治性複合部分発作 ・ビガバトリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ビガバトリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ビガバトリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ビガバトリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ビガバトリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Vigabatrin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vigabatrin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Vigabatrin market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Vigabatrin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Powder
Market segment by Application can be divided into
Infantile Spasms (IS)
Partial-Onset Seizures
Refractory Complex Partial Seizures
The key market players for global Vigabatrin market are listed below:
Sanofi
Benta Pharma Industries
Dr. Fisher Farma
Lundbeck
Novartis
Perrigo
Grindeks
Endo International
Amneal Pharma
Cipla
Upsher-Smith
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Vigabatrin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vigabatrin, with price, sales, revenue and global market share of Vigabatrin in 2018 and 2019.
Chapter 3, the Vigabatrin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vigabatrin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Vigabatrin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Vigabatrin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Vigabatrin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vigabatrin Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Tablet
1.2.3 Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global Vigabatrin Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Infantile Spasms (IS)
1.3.3 Partial-Onset Seizures
1.3.4 Refractory Complex Partial Seizures
1.4 Global Vigabatrin Market Size & Forecast
1.4.1 Global Vigabatrin Sales in Value (2016-2026))
1.4.2 Global Vigabatrin Sales in Volume (2016-2026)
1.4.3 Global Vigabatrin Price by Type (2016-2026) & (US$/Unit)
1.5 Global Vigabatrin Production Capacity Analysis
1.5.1 Global Vigabatrin Total Production Capacity (2016-2026)
1.5.2 Global Vigabatrin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Vigabatrin Market Drivers
1.6.2 Vigabatrin Market Restraints
1.6.3 Vigabatrin Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Vigabatrin Product and Services
2.1.4 Sanofi Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Benta Pharma Industries
2.2.1 Benta Pharma Industries Details
2.2.2 Benta Pharma Industries Major Business
2.2.3 Benta Pharma Industries Vigabatrin Product and Services
2.2.4 Benta Pharma Industries Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Dr. Fisher Farma
2.3.1 Dr. Fisher Farma Details
2.3.2 Dr. Fisher Farma Major Business
2.3.3 Dr. Fisher Farma Vigabatrin Product and Services
2.3.4 Dr. Fisher Farma Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Lundbeck
2.4.1 Lundbeck Details
2.4.2 Lundbeck Major Business
2.4.3 Lundbeck Vigabatrin Product and Services
2.4.4 Lundbeck Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Vigabatrin Product and Services
2.5.4 Novartis Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Perrigo
2.6.1 Perrigo Details
2.6.2 Perrigo Major Business
2.6.3 Perrigo Vigabatrin Product and Services
2.6.4 Perrigo Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Grindeks
2.7.1 Grindeks Details
2.7.2 Grindeks Major Business
2.7.3 Grindeks Vigabatrin Product and Services
2.7.4 Grindeks Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Endo International
2.8.1 Endo International Details
2.8.2 Endo International Major Business
2.8.3 Endo International Vigabatrin Product and Services
2.8.4 Endo International Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Amneal Pharma
2.9.1 Amneal Pharma Details
2.9.2 Amneal Pharma Major Business
2.9.3 Amneal Pharma Vigabatrin Product and Services
2.9.4 Amneal Pharma Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Cipla
2.10.1 Cipla Details
2.10.2 Cipla Major Business
2.10.3 Cipla Vigabatrin Product and Services
2.10.4 Cipla Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Upsher-Smith
2.11.1 Upsher-Smith Details
2.11.2 Upsher-Smith Major Business
2.11.3 Upsher-Smith Vigabatrin Product and Services
2.11.4 Upsher-Smith Vigabatrin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Vigabatrin Sales by Manufacturer
3.1 Global Vigabatrin Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Vigabatrin Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Vigabatrin
3.4 Market Concentration Rate
3.4.1 Top 3 Vigabatrin Manufacturer Market Share
3.4.2 Top 6 Vigabatrin Manufacturer Market Share
3.5 Global Vigabatrin Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Vigabatrin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Vigabatrin Market Size by Region
4.1.1 Global Vigabatrin Sales in Volume by Region (2016-2026)
4.1.2 Global Vigabatrin Revenue by Region (2016-2026)
4.2 North America Vigabatrin Revenue (2016-2026)
4.3 Europe Vigabatrin Revenue (2016-2026)
4.4 Asia-Pacific Vigabatrin Revenue (2016-2026)
4.5 South America Vigabatrin Revenue (2016-2026)
4.6 Middle East and Africa Vigabatrin Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Vigabatrin Sales in Volume by Type (2016-2026)
5.2 Global Vigabatrin Revenue by Type (2016-2026)
5.3 Global Vigabatrin Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Vigabatrin Sales in Volume by Application (2016-2026)
6.2 Global Vigabatrin Revenue by Application (2016-2026)
6.3 Global Vigabatrin Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Vigabatrin Sales by Type (2016-2026)
7.2 North America Vigabatrin Sales by Application (2016-2026)
7.3 North America Vigabatrin Market Size by Country
7.3.1 North America Vigabatrin Sales in Volume by Country (2016-2026)
7.3.2 North America Vigabatrin Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Vigabatrin Sales by Type (2016-2026)
8.2 Europe Vigabatrin Sales by Application (2016-2026)
8.3 Europe Vigabatrin Market Size by Country
8.3.1 Europe Vigabatrin Sales in Volume by Country (2016-2026)
8.3.2 Europe Vigabatrin Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Vigabatrin Sales by Type (2016-2026)
9.2 Asia-Pacific Vigabatrin Sales by Application (2016-2026)
9.3 Asia-Pacific Vigabatrin Market Size by Region
9.3.1 Asia-Pacific Vigabatrin Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Vigabatrin Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Vigabatrin Sales by Type (2016-2026)
10.2 South America Vigabatrin Sales by Application (2016-2026)
10.3 South America Vigabatrin Market Size by Country
10.3.1 South America Vigabatrin Sales in Volume by Country (2016-2026)
10.3.2 South America Vigabatrin Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Vigabatrin Sales by Type (2016-2026)
11.2 Middle East & Africa Vigabatrin Sales by Application (2016-2026)
11.3 Middle East & Africa Vigabatrin Market Size by Country
11.3.1 Middle East & Africa Vigabatrin Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Vigabatrin Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Vigabatrin Typical Distributors
12.3 Vigabatrin Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Vigabatrin Revenue by Type, (USD Million), 2021-2026
Table 2. Global Vigabatrin Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Vigabatrin Product and Services
Table 6. Sanofi Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Benta Pharma Industries Basic Information, Manufacturing Base and Competitors
Table 8. Benta Pharma Industries Major Business
Table 9. Benta Pharma Industries Vigabatrin Product and Services
Table 10. Benta Pharma Industries Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Dr. Fisher Farma Basic Information, Manufacturing Base and Competitors
Table 12. Dr. Fisher Farma Major Business
Table 13. Dr. Fisher Farma Vigabatrin Product and Services
Table 14. Dr. Fisher Farma Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 16. Lundbeck Major Business
Table 17. Lundbeck Vigabatrin Product and Services
Table 18. Lundbeck Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Vigabatrin Product and Services
Table 22. Novartis Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Perrigo Basic Information, Manufacturing Base and Competitors
Table 24. Perrigo Major Business
Table 25. Perrigo Vigabatrin Product and Services
Table 26. Perrigo Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Grindeks Basic Information, Manufacturing Base and Competitors
Table 28. Grindeks Major Business
Table 29. Grindeks Vigabatrin Product and Services
Table 30. Grindeks Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Endo International Basic Information, Manufacturing Base and Competitors
Table 32. Endo International Major Business
Table 33. Endo International Vigabatrin Product and Services
Table 34. Endo International Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Amneal Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Amneal Pharma Major Business
Table 37. Amneal Pharma Vigabatrin Product and Services
Table 38. Amneal Pharma Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cipla Basic Information, Manufacturing Base and Competitors
Table 40. Cipla Major Business
Table 41. Cipla Vigabatrin Product and Services
Table 42. Cipla Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Upsher-Smith Basic Information, Manufacturing Base and Competitors
Table 44. Upsher-Smith Major Business
Table 45. Upsher-Smith Vigabatrin Product and Services
Table 46. Upsher-Smith Vigabatrin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Vigabatrin Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Vigabatrin Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Vigabatrin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Vigabatrin Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Vigabatrin Production Site of Key Manufacturer
Table 52. Vigabatrin New Entrant and Capacity Expansion Plans
Table 53. Vigabatrin Mergers & Acquisitions in the Past Five Years
Table 54. Global Vigabatrin Sales by Region (2016-2021e) & (K Units)
Table 55. Global Vigabatrin Sales by Region (2021-2026) & (K Units)
Table 56. Global Vigabatrin Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Vigabatrin Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Vigabatrin Sales by Type (2016-2021e) & (K Units)
Table 59. Global Vigabatrin Sales by Type (2021-2026) & (K Units)
Table 60. Global Vigabatrin Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Vigabatrin Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Vigabatrin Price by Type (2016-2021e) & (US$/Unit)
Table 63. Global Vigabatrin Price by Type (2021-2026) & (US$/Unit)
Table 64. Global Vigabatrin Sales by Application (2016-2021e) & (K Units)
Table 65. Global Vigabatrin Sales by Application (2021-2026) & (K Units)
Table 66. Global Vigabatrin Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Vigabatrin Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Vigabatrin Price by Application (2016-2021e) & (US$/Unit)
Table 69. Global Vigabatrin Price by Application (2021-2026) & (US$/Unit)
Table 70. North America Vigabatrin Sales by Country (2016-2021e) & (K Units)
Table 71. North America Vigabatrin Sales by Country (2021-2026) & (K Units)
Table 72. North America Vigabatrin Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Vigabatrin Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Vigabatrin Sales by Type (2016-2021e) & (K Units)
Table 75. North America Vigabatrin Sales by Type (2021-2026) & (K Units)
Table 76. North America Vigabatrin Sales by Application (2016-2021e) & (K Units)
Table 77. North America Vigabatrin Sales by Application (2021-2026) & (K Units)
Table 78. Europe Vigabatrin Sales by Country (2016-2021e) & (K Units)
Table 79. Europe Vigabatrin Sales by Country (2021-2026) & (K Units)
Table 80. Europe Vigabatrin Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Vigabatrin Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Vigabatrin Sales by Type (2016-2021e) & (K Units)
Table 83. Europe Vigabatrin Sales by Type (2021-2026) & (K Units)
Table 84. Europe Vigabatrin Sales by Application (2016-2021e) & (K Units)
Table 85. Europe Vigabatrin Sales by Application (2021-2026) & (K Units)
Table 86. Asia-Pacific Vigabatrin Sales by Region (2016-2021e) & (K Units)
Table 87. Asia-Pacific Vigabatrin Sales by Region (2021-2026) & (K Units)
Table 88. Asia-Pacific Vigabatrin Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Vigabatrin Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Vigabatrin Sales by Type (2016-2021e) & (K Units)
Table 91. Asia-Pacific Vigabatrin Sales by Type (2021-2026) & (K Units)
Table 92. Asia-Pacific Vigabatrin Sales by Application (2016-2021e) & (K Units)
Table 93. Asia-Pacific Vigabatrin Sales by Application (2021-2026) & (K Units)
Table 94. South America Vigabatrin Sales by Country (2016-2021e) & (K Units)
Table 95. South America Vigabatrin Sales by Country (2021-2026) & (K Units)
Table 96. South America Vigabatrin Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Vigabatrin Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Vigabatrin Sales by Type (2016-2021e) & (K Units)
Table 99. South America Vigabatrin Sales by Type (2021-2026) & (K Units)
Table 100. South America Vigabatrin Sales by Application (2016-2021e) & (K Units)
Table 101. South America Vigabatrin Sales by Application (2021-2026) & (K Units)
Table 102. Middle East & Africa Vigabatrin Sales by Country (2016-2021e) & (K Units)
Table 103. Middle East & Africa Vigabatrin Sales by Country (2021-2026) & (K Units)
Table 104. Middle East & Africa Vigabatrin Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Vigabatrin Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Vigabatrin Sales by Type (2016-2021e) & (K Units)
Table 107. Middle East & Africa Vigabatrin Sales by Type (2021-2026) & (K Units)
Table 108. Middle East & Africa Vigabatrin Sales by Application (2016-2021e) & (K Units)
Table 109. Middle East & Africa Vigabatrin Sales by Application (2021-2026) & (K Units)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Vigabatrin Typical Distributors
Table 113. Vigabatrin Typical Customers
List of Figures
Figure 1. Vigabatrin Picture
Figure 2. Global Vigabatrin Sales Market Share by Type in 2020
Figure 3. Tablet
Figure 4. Powder
Figure 5. Global Vigabatrin Sales Market Share by Application in 2020
Figure 6. Infantile Spasms (IS)
Figure 7. Partial-Onset Seizures
Figure 8. Refractory Complex Partial Seizures
Figure 9. Global Vigabatrin Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Vigabatrin Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Vigabatrin Sales (2016-2026) & (K Units)
Figure 12. Global Vigabatrin Price by Type (2016-2026) & (US$/Unit)
Figure 13. Global Vigabatrin Production Capacity (2016-2026) & (K Units)
Figure 14. Global Vigabatrin Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Vigabatrin Market Drivers
Figure 16. Vigabatrin Market Restraints
Figure 17. Vigabatrin Market Trends
Figure 18. Global Vigabatrin Sales Market Share by Manufacturer in 2020
Figure 19. Global Vigabatrin Revenue Market Share by Manufacturer in 2020
Figure 20. Vigabatrin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Vigabatrin Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Vigabatrin Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Vigabatrin Sales Market Share by Region (2016-2026)
Figure 24. Global Vigabatrin Revenue Market Share by Region (2016-2026)
Figure 25. North America Vigabatrin Revenue (2016-2026) & (USD Million)
Figure 26. Europe Vigabatrin Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Vigabatrin Revenue (2016-2026) & (USD Million)
Figure 28. South America Vigabatrin Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Vigabatrin Revenue (2016-2026) & (USD Million)
Figure 30. Global Vigabatrin Sales Market Share by Type (2016-2026)
Figure 31. Global Vigabatrin Revenue Market Share by Type (2016-2026)
Figure 32. Global Vigabatrin Price by Type (2016-2026) & (US$/Unit)
Figure 33. Global Vigabatrin Sales Market Share by Application (2016-2026)
Figure 34. Global Vigabatrin Revenue Market Share by Application (2016-2026)
Figure 35. Global Vigabatrin Price by Application (2016-2026) & (US$/Unit)
Figure 36. North America Vigabatrin Sales Market Share by Type (2016-2026)
Figure 37. North America Vigabatrin Sales Market Share by Application (2016-2026)
Figure 38. North America Vigabatrin Sales Market Share by Country (2016-2026)
Figure 39. North America Vigabatrin Revenue Market Share by Country (2016-2026)
Figure 40. United States Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Vigabatrin Sales Market Share by Type (2016-2026)
Figure 44. Europe Vigabatrin Sales Market Share by Application (2016-2026)
Figure 45. Europe Vigabatrin Sales Market Share by Country (2016-2026)
Figure 46. Europe Vigabatrin Revenue Market Share by Country (2016-2026)
Figure 47. Germany Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Vigabatrin Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Vigabatrin Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Vigabatrin Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Vigabatrin Revenue Market Share by Region (2016-2026)
Figure 56. China Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Vigabatrin Sales Market Share by Type (2016-2026)
Figure 63. South America Vigabatrin Sales Market Share by Application (2016-2026)
Figure 64. South America Vigabatrin Sales Market Share by Country (2016-2026)
Figure 65. South America Vigabatrin Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Vigabatrin Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Vigabatrin Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Vigabatrin Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Vigabatrin Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Vigabatrin Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のパーシャルアイラッシュカーラー市場 2021：企業別、地域別、種類・用途別 The Partial Eyelash Curler market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 部分放電監視システムの世界市場2018-2025 Partial discharge monitoring systems can be used for permanent surveillance of insulation systems on GIS, transformers, rotating machines, motors, cables, or other high voltage equipment. These instruments are designed for long term data recording, alarm handling, event recognition, and system integ…
- 世界のエベロリムス薬品市場 2021：企業別、地域別、種類・用途別 The Everolimus Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- 世界のグレプトフェロン（鉄-デキストランヘプトン酸複合体）市場 2021：企業別、地域別、種類・用途別 The Gleptoferron (Iron-Dextran Heptonic Acid Complex) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 世界のムライト耐火物市場 2021：企業別、地域別、種類・用途別 The Mullite Refractory market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…